TGA issues updated warnings for RSV vaccines

Safety information for two RSV vaccines is being updated to “reflect the low risk of people contracting Guillain-Barre syndrome following vaccination  Immunisers are being advised to be aware of the higher Guillain-Barre syndrome (GBS) risk after administering the Arexvy or Abrysvo respiratory syncytial virus (RSV) vaccines.   Announcing the update to the safety information of